Please login to the form below

Not currently logged in
Email:
Password:

KRAS inhibitor

This page shows the latest KRAS inhibitor news and features for those working in and with pharma, biotech and healthcare.

Merck strengthens KRAS stake with Taiho and Astex partnership

Merck strengthens KRAS stake with Taiho and Astex partnership

Another company looking to crack the KRAS mutation is Amgen, which recently announced some positive data for its pathfinder KRAS inhibitor AMG 510 in KRAS G12C-positive NSCLC. ... Other competitors in the KRAS inhibitor race include Mirati, Boehringer

Latest news

  • Amgen buys BeiGene stake for $2.7bn to aid push into China Amgen buys BeiGene stake for $2.7bn to aid push into China

    Included in that part of the deal however is Amgen’s much-anticipated KRAS inhibitor  AMG 510, and its bispecific antibody pipeline featuring anti-BCMA candidate  AMG 420.

  • Amgen reveals more data on KRAS drug Amgen reveals more data on KRAS drug

    Unveiled an overall disease control rate of 100%. Amgen has revealed more data for its pathfinder KRAS inhibitor AMG 510, building its case for the drug as a treatment for KRAS ... AMG 510 became the first KRAS inhibitor to show activity in a 35-patient

  • Boehringer bolsters KRAS push with $720m Lupin deal Boehringer bolsters KRAS push with $720m Lupin deal

    Signs of progress in the field are emerging. Boehringer Ingelheim has licensed a MEK inhibitor from India’s Lupin that it intends to pair with its stable of KRAS inhibitors, a ... Other companies including Johnson &Johnson and Mirati are also working

  • So far so good for Amgen's much-anticipated KRAS inhibitor So far so good for Amgen's much-anticipated KRAS inhibitor

    Promise to hit previously 'undruggable' target. Amgen has the first clinical data for its inhibitor of KRAS, a cancer target long though to be almost undruggable despite its promise. ... Amgen is in a race with Mirati Therapeutics to bring a KRAS G12C

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics